Eoin O'connell
St. Vincent's University Healthcare Group, Dublin 4
Dublin, L, Ireland
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Biomarker profiling for risk of future heart failure (HFpEF) development.
Journal: Journal of translational medicine
Published: September 10, 2020
New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure.
Journal: European journal of heart failure
Published: June 30, 2019
Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community.
Journal: Journal of cellular and molecular medicine
Published: September 18, 2018
Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis.
Journal: Scientific reports
Published: July 28, 2017
Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: April 07, 2016
Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
Journal: European journal of heart failure
Published: November 14, 2014
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
Journal: European journal of heart failure
Published: August 28, 2014
Life expectancy for community-based patients with heart failure from time of diagnosis.
Journal: International journal of cardiology
Published: March 24, 2014
Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population?
Journal: Circulation. Heart failure
Published: February 05, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026